What technology area does this patent fall under?

Primary CPC classification C07K14/00. Mapped technology areas include Chemistry & Metallurgy.

When was this patent published?

Publication date Tue Jul 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.

What related patents are in patentsdb?

We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).

Polypeptides for use in self-assembling protein nanostructures

Patent metadata
Field	Value
Publication number	US-10351603-B2
Application number	US-201715490351-A
Country	US
Kind code	B2
Filing date	Apr 18, 2017
Priority date	Nov 3, 2014
Publication date	Jul 16, 2019
Grant date	Jul 16, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

Title
What the patent document calls the invention.
Abstract
A short plain-language summary of the technical disclosure.
Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
Key dates
Filing, priority, publication, and grant dates set the timeline.
First independent claim
The legal scope of protection — read this for what is actually claimed.
CPC / IPC classifications
Technology tags used to group this patent with similar filings.
Citations and related patents
Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Synthetic nanostructures, polypeptides that are useful, for example, in making synthetic nanostructures, and methods for using such synthetic nanostructures are disclosed herein.

First claim

Opening claim text (preview).

We claim: 1. A recombinant nucleic acid encoding a polypeptide comprising an amino acid sequence that is at least 75% identical over its length, and identical at least at one identified interface position, to the amino acid sequence of a polypeptide selected from the group consisting of SEQ ID NOS:1-34: Name Amino Acid Sequence Identified interface residues I53-34A MEGMDPLAVLAESRLLPLLTVRGGEDLAGLATVLELMGVGALEITL I53-34A: SEQ ID RTEKGLEALKALRKSGLLLGAGTVRSPKEAEAALEAGAAFLVSPGL 28, 32, 36, 37, 186, 188, 191, 192, 195 NO: 1 LEEVAALAQARGVPYLPGVLTPTEVERALALGLSALKFFPAEPFQG VRVLRAYAEVEPEVRELPTGGIKEEHLPHYAALPNLLAVGGSWLLQ GDLAAVMKKVKAAKALLSPQAPG I53-34B MTKKVGIVDTTFARVDMAEAAIRTLKALSPNIKIIRKTVPGIKDLPV I53-34B: SEQ ID ACKKLLEEEGCDIVMALGMPGKAEKDKVCAHEASLGLMLAQLMT 19, 20, 23, 24, 27, 109, 113, 116, 117, NO: 2 NKHIIEVFVHEDEAKDDDELDILALVRAIEHAANVYYLLFKPEYLTR 120, 124, 148 MAGKGLRQGREDAGPARE I53-40A MTKKVGIVDTTFARVDMASAAILTLKMESPNIKIIRKTVPGIKDLPV I53-40A: SEQ ID ACKKLLEEEGCDIVMALGMPGKAEKDKVCAHEASLGLMLAQLMT 20, 23, 24, 27, 28, 109, 112, 113, 116, NO: 3 NKHIIEVFVHEDEAKDDAELKILAARRAIEHALNVYYLLFKPEYLTR 120, 124 MAGKGLRQGEEDAGPARE I53-40B MSTINNQLKALKVIPVIAIDNAEDIIPLGKVLAENGLPAAEITERSSAA I53-40B: 47, 51, 54, 58, 74, 102 SEQ ID VKAIMLLRSAQPEMLIGAGTILNGVQALAAKEAGATFVVSPGFNPN NO: 4 TVRACQIIGIDIVPGVNNPSTVEAALEMGLTTLKFFPAEASGGISMV KSLVGPYGDIRLMPTGGITPSNIDNYLAIPQVLACGGTWMVDKKLV TNGEWDEIARLTREIVEQVNP I53-47A MPIFTLNTNIKATDVPSDFLSLTSRLVGLILSKPGSYVAVHINTDQQL I53-47A: 22, 25, 29, 72, 79, 86, 87 SEQ ID SFGGSTNPAAFGTLMSIGGIEPSKNRDHSAVLFDHLNAMLGIPKNR NO: 5 MYIHFVNLNGDDVGWNGTTF I53-47B MNQHSHKDYETVRIAVVRARWHADIVDACVEAFEIAMAAIGGDRF I53-47B: SEQ ID AVDVFDVPGAYEIPLHARTLAETGRYGAVLGTAFVVNGGIYRHEFV 28, 31, 35, 36, 39, 131, 132, 135, 139, NO: 6 ASAVIDGMMNVQLSTGVPVLSAVLTPHRYRDSAEHHRFFAAHFAV 146 KGVEAARACIEILAAREKIAA I53-50A MKMEELFKKHKIVAVLRANSVEEAIEKAVAVFAGGVHLIEITFTVP I53-50A: 25, 29, 33, 54, 57 SEQ ID DADTVIKALSVLKEKGAIIGAGTVTSVEQCRKAVESGAEFIVSPHLD NO: 7 EEISQFCKEKGVFYMPGVMTPTELVKAMKLGHTILKLFPGEVVGPQ FVKAMKGPFPNVKFVPTGGVNLDNVCEWFKAGVLAVGVGSALVK GTPDEVREKAKAFVEKIRGCTE I53-50B MNQHSHKDYETVRIAVVRARWHAEIVDACVSAFEAAMADIGGDR I53-50B: SEQ ID FAVDVFDVPGAYEIPLHARTLAETGRYGAVLGTAFVVNGGIYRHEF 24, 28, 36, 124, 125, 127, 128, 129, NO: 8 VASAVIDGMMNVQLSTGVPVLSAVLTPHRYRDSDAHTLLFLALFA 131, 132, 133, 135, 139 VKGMEAARACVEILAAREKIAA I53-51A MFTKSGDDGNTNVINKRVGKDSPLVNFLGDLDELNSFIGFAISKIPW I53-51A: SEQ ID EDMKKDLERVQVELFEIGEDLSTQSSKKKIDESYVLWLLAATAIYRI 80, 83, 86, 87, 88, 90, 91, 94, 166, 172, NO: 9 ESGPVKLFVIPGGSEEASVLHVTRSVARRVERNAVKYTKELPEINR 176 MIIVYLNRLSSLLFAMALVANKRRNQSEKIYEIGKSW I53-51B MNQHSHKDYETVRIAVVRARWHADIVDQCVRAFEEAMADAGGDR I53-51B: SEQ ID FAVDVFDVPGAYEIPLHARTLAETGRYGAVLGTAFVVNGGIYRHEF 31, 35, 36, 40, 122, 124, 128, 131, 135, NO: 10 VASAVIDGMMNVQLSTGVPVLSAVLTPHRYRSSREHHEFFREHFM 139, 143, 146, 147 VKGVEAAAACITILAAREKIAA I52-03A MGHTKGPTPQQHDGSALRIGIVHARWNKTIIMPLLIGTIAKLLECGV I52-03A: 28, 32, 36, 39, 44, 49 SEQ ID KASNIVVQSVPGSWELPIAVQRLYSASQLQTPSSGPSLSAGDLLGSS NO: 11 TTDLTALPTTTASSTGPFDALIAIGVLIKGETMHFEYIADSVSHGLMR VQLDTGVPVIFGVLTVLTDDQAKARAGVIEGSHNHGEDWGLAAVE MGVRRRDWAAGKTE I52-03B MYEVDHADVYDLFYLGRGKDYAAEASDIADLVRSRTPEASSLLDV I52-03B: 94, 115, 116, 206, 213 SEQ ID ACGTGTHLEHFTKEFGDTAGLELSEDMLTHARKRLPDATLHQGDM NO: 12 RDFQLGRKFSAVVSMFSSVGYLKTVAELGAAVASFAEHLEPGGVV

Assignees

Univ Washington

Inventors

Classifications

C07K14/00Primary
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof · CPC title

Patent family

Related publications grouped by family.

View patent family 55851914

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10351603B2 cover?: Synthetic nanostructures, polypeptides that are useful, for example, in making synthetic nanostructures, and methods for using such synthetic nanostructures are disclosed herein.
Who is the assignee on this patent?: Univ Washington
What technology area does this patent fall under?: Primary CPC classification C07K14/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?: Publication date Tue Jul 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?: We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).